Linda Avey (née Bahnson[not verified in body]) is an American biologist and entrepreneur.

[3][independent source needed][4] Avey began her scientific career in 1982 at University of California, Irvine as a staff research associate.

[citation needed] As of 2024, a site to which Avey submits information was stating that she had "over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C."[3][6] She has stated that she worked for Perlegen Sciences and for Affymetrix[when?]

[14][better source needed] In 2018, Avey and Aneil Mallavarapu began collaboration with Naryana Health to focus on collecting and analyzing genetic information from populations often economically excluded, via their further start-up, Precisely, Inc.[15][16][17] Avey is an advisor to Verily Life Sciences and is on the Board of Fellows at Stanford Medical School.

[17] In November of 2023, Avey joined the Board of Directors of the Human Immunome Project (HIP).